Home » Stocks » ODYY

Odyssey Group International Inc. (ODYY)

Stock Price: $0.6600 USD -0.0400 (-5.71%)
Updated May 10, 2021 3:57 PM EDT - Market closed
Market Cap 61.89M
Revenue (ttm) n/a
Net Income (ttm) -3.91M
Shares Out 99.82M
EPS (ttm) -0.04
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 10
Last Price $0.6600
Previous Close $0.7000
Change ($) -0.0400
Change (%) -5.71%
Day's Open 0.7750
Day's Range 0.6100 - 0.7750
Day's Volume 65,106
52-Week Range 0.1050 - 3.1000

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

IRVINE, CA, May 13, 2021 (GLOBE NEWSWIRE) --  Odyssey Group International, Inc. (OTCQB: ODYY ) (the "Company" or "Odyssey"),a technology and asset acquisition company focused on developing unique, life-...

6 hours ago - GlobeNewsWire

Irvine, CA, April 14, 2021 (GLOBE NEWSWIRE) -- Odyssey Group International, Inc. (OTCQB: ODYY ) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, lif...

4 weeks ago - GlobeNewsWire

CEO Michael Redmond to Highlight the Company's Strategy in Developing and Acquiring Life-Saving Medical Products IRVINE, CA / ACCESSWIRE / March 22, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY)...

1 month ago - Accesswire

Inaugural members of the Sports Advisory Board (SAB) include Kurt Warner, Brett Favre, Mark Rypien, David Ross and Steve “Mooch” Mariucci Inaugural members of the Sports Advisory Board (SAB) include Kur...

1 month ago - GlobeNewsWire

IRVINE, CA / ACCESSWIRE / March 10, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY) (the "Company" or "Odyssey"), a technology and asset acquisition company focused on developing unique, life-savi...

2 months ago - Accesswire

Anticipates initiation of Phase 1 clinical trials of PRV-002 during the Second Quarter of 2021 IRVINE, CA / ACCESSWIRE / March 2, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY) ("Odyssey"), a tec...

2 months ago - Accesswire

All Stock Transaction Phase 1 Clinical Trial Site, Protocol and CRO Established IRVINE, CA / ACCESSWIRE / January 11, 2021 / Odyssey Group International, Inc. (OTCQB:ODYY) (the “Company” or “Odyssey”), ...

4 months ago - Accesswire

About ODYY

Odyssey Group International, Inc. focuses on development, acquisition, and commercialization of medical products and health related technologies. It intends to offer medical devices. The company has development projects in three technologies, including CardioMap, a heart monitoring and screening device; Save A Life choking rescue device; and a neurosteroid drug compound intended to treat rare brain disorders. Odyssey Group International, Inc. was founded in 2014 and is based in Irvine, California.

Industry
Medical Devices
Founded
2014
Stock Exchange
OTCMKTS
Ticker Symbol
ODYY
Full Company Profile

Financial Performance

Financial Statements